Action on Hearing Loss Logo
    Total results:
    Search
      Total results:

      COMiT'ID study update improving the future of tinnitus research

      Professor Deb Hall, Deputy Director of the National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, shares the key findings of her group’s research study to improve the design of future trials for evaluating tinnitus treatments. Action on Hearing Loss has contributed some funding in support of COMIT’ID.

      By: Professor Deb Hall | 11 January 2018

      COMIT’ID (Core Outcomes Measures in Tinnitus - International Delphi survey) - study update November 2017

      The COMiT’ID study aims to improve the quality of future clinical research by identifying a minimum standard for assessing how a tinnitus treatment has worked. COMiT’ID has involved the global tinnitus community with over 600 people taking part from over 40 countries. Thank you for all your support!

       

      Three separate online consensus surveys have now been completed to identify how sound-, psychology- and drug-based tinnitus treatments should be commonly assessed before and after treatment. A wide range of people took part based on their experience with one or more of these treatment types. These included people with lived experience of tinnitus, healthcare professionals, researchers, industry experts and funders of tinnitus research.  

      From each online survey, participants all agreed on around 20 different tinnitus-related problems to recommend to researchers for assessing in a clinical trial. From a practical point of view however, this number is too many for investigators to measure in a clinical research study. So, survey participants were invited to attend one of three consensus workshops (one for each treatment type). Twenty participants – people with lived experience of tinnitus and professionals – took part in each workshop to discuss the findings. They agreed that the list of recommended tinnitus assessments should be reduced to a more manageable number, creating a minimum set that will become international standards to be used in research. This minimum set was selected by those attending the workshops on the basis that assessments are: i) directly relevant to patients with tinnitus, to the healthcare professionals giving the treatment, and to the researchers designing the trial, ii) directly relevant to how the treatment is supposed to be working, and iii) are expected to be very sensitive to change during the treatment.   

      Although the three online surveys and workshops for sound-based, psychology-based and drug-based tinnitus treatment were all completed separately, everyone taking part in the COMIT’ID study agreed that tinnitus intrusiveness is important and critical to measure. Over 85% of participants said that tinnitus intrusiveness was important, no matter which type of tinnitus treatment is being tested and no matter which stakeholder group was asked. Tinnitus intrusiveness describes the state of noticing the sound of tinnitus is there and it is invading your life or your personal space. 

      Here are the other core assessments that our stakeholders recommend to investigators. These are our minimal reporting standards which will enable findings to be compared across studies. Investigators will always be free to add other assessments to their clinical trial design, if they wish. 

      Our next steps will be to define exactly what each of the assessments means to the community so that we can make recommendations on how they should be measured.

      Sound-based treatments

      Psychology-based treatments

      drug-based treatments


      tinnitus intrusiveness tinnitus intrusiveness tinnitus intrusiveness
      ability to ignore tinnitus acceptance tinnitus loudness
      concentration mood (including feelings of anxiety and depression)  
      quality of sleep negative thoughts and beliefs  
      sense of control sense of control  
                                         

      Find out more: 

      We depend on your donations so we can fund the best hearing and tinnitus research around the world. Donate today and help us continue our vital work into hearing treatments, so that people can live life to the full again.

      Stay informed on our progress on Twitter @COMITIDStudy 

      This research was funded by: Biomedicine and Molecular Biosciences European Cooperation in Science and Technology (COST) Action framework (TINNET BM1306), Action on Hearing Loss, British Tinnitus Association, National Institute for Health Research

      Recent Posts

      Preventing hearing loss: the search for treatments

      Medicines like aminoglycoside antibiotics or cisplatin are used to combat life-threatening infections and cancer, respectively, but their use may come at the price of someone’s hearing. Several treatments to prevent the loss of hearing caused by these medicines are currently being developed. Our Translational Research Manager, Dr Carina Santos, tells us more.

      By: Dr Carina Santos
      12 October 2018

      Shining a light on the cochlea

      We fund research across the globe into treatments for hearing loss and tinnitus. One of our newest projects, at the Bionics Institute in Australia, is investigating if we can improve how well cochlear implants work using light.

      By: Dr Tracey Pollard
      11 October 2018

      Scientifically speaking

      A project based at Cincinnati Children’s Hospital in the US is using virtual reality technology to assess children’s hearing. Dr Hannah Stewart tells us how.

      By: Dr Hannah Stewart
      11 October 2018

      Mental wellbeing, hearing loss, and the workplace

      Our research and policy officer, Rowena, brings us her insights into mental health and hearing loss in the workplace. She explains how employers can help combat stigma – and foster a supportive culture.

      By: Rowena Stobart
      09 October 2018

      Recent Posts

      Preventing hearing loss: the search for treatments

      Medicines like aminoglycoside antibiotics or cisplatin are used to combat life-threatening infections and cancer, respectively, but their use may come at the price of someone’s hearing. Several treatments to prevent the loss of hearing caused by these medicines are currently being developed. Our Translational Research Manager, Dr Carina Santos, tells us more.

      By: Dr Carina Santos
      12 October 2018

      Shining a light on the cochlea

      We fund research across the globe into treatments for hearing loss and tinnitus. One of our newest projects, at the Bionics Institute in Australia, is investigating if we can improve how well cochlear implants work using light.

      By: Dr Tracey Pollard
      11 October 2018

      Scientifically speaking

      A project based at Cincinnati Children’s Hospital in the US is using virtual reality technology to assess children’s hearing. Dr Hannah Stewart tells us how.

      By: Dr Hannah Stewart
      11 October 2018

      Mental wellbeing, hearing loss, and the workplace

      Our research and policy officer, Rowena, brings us her insights into mental health and hearing loss in the workplace. She explains how employers can help combat stigma – and foster a supportive culture.

      By: Rowena Stobart
      09 October 2018

      More like this

      We're really proud of everyone who's a part of Action on Hearing Loss, and hope you'll feel inspired to become a part of our community.​

      We campaign for changes that make life better for people who are confronting deafness, tinnitus and hearing loss.

      Our ears are our organs of hearing and balance. They have three parts: the outer, middle and inner ear.